Johns Hopkins Study discovers cancer in the blood 3 years before the diagnosis

Researchers at Johns Hopkins University say they discovered an advanced method Discovering cancer.

A new study, published in the magazine of Cancer Discovery, was partially funded by the National Health Institutes, that the genetic substances raised by the tumors in the bloodstream can be discovered three years ago Diagnosis of cancer.

The researchers analyzed the plasma samples of the risk of large arteriosclerosis in societies (ARIC) to assess the risk factors of heart attack, stroke, heart failure and other cardiovascular disease, according to a press statement.

Food and Drug Administration (FDA)

Blood samples were analyzed from 26 participants who were diagnosed with cancer within six months of the collection of samples, and 26 of those who were not diagnosed with cancer.

Among these 52 participants, eight positive records in the Middle Cancer early detection laboratory test and were diagnosed with cancer within four months after blood collection.

Mctive tests are a experimental type of cancer examination that is looking for signs of multiple types of cancer at the same time, according to the American Cancer Society. These signs may include pieces of DNA, RNA or proteins of abnormal cells.

Click here to register in our health newsletter

For six of these eight individuals, researchers were able to assess additional blood samples collected from 3.1 to 3.5 years before the diagnosis.

In four samples, The researchers identified Tumor mutations (genetic changes within cancer cells).

The author of the study in the study, Uxwan Wang, PhD, Assistant Professor of Oncology at the Faculty of Medicine at Johns Hopkins University, participated in a statement that the investigators were surprised by the results.

“Three years ago it saves time to intervene,” she said. “The tumors are likely to be less advanced and probably To be treatmentable“

For more health articles, visit www.foxnews.com/health

The prominent study author Bert Voglstein, a doctorate in medicine, Professor of Clayton in Oncology and co -manager of the Ludwig Center in Jones Hopkins, said that the study shows “MecED tests in the discovery of cancer very early, and determines the standard sensitivities required for their success.”

Discovery of cancer can help years before the clinical diagnosis “providing the administration with more FavorableThe great author Nicholas Papadubulus, PhD, Professor of Oncology Center and Ludwig Center investigator.

Click here to get the Fox News app

“Of course, we need to define the appropriate clinical follow -up after a positive test of such cancer,” he added.

Fox News Digital contacts with Johns Hopkins for comment.